Molecular glue degraders are generally perceived to have better pharmacological properties than PROTAC because they have a relatively small molecular weight.
However, a specific target protein can be selected by PROTAC, whereas a target protein that is degraded by molecular glue is often found serendipitously.

Through a logically designed peptide library and screening technique, Pin is developing new molecular glue degraders and platform technologies that can efficiently identify and selectively degrade target proteins.